Global Opioids Market Report 2022: Featuring Purdue, Johnson & Johnson, Hikma Pharmaceuticals, Pfizer, Abbvie, Sanofi, Sun Pharmaceutical, Grunenthal & Merck – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Opioids Market Size, Share & Trends Analysis Report by Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), by Application (Pain Relief, Anesthesia), by Route Of Administration, by Distribution Channel, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global opioids market size is expected to reach USD 25.33 billion by 2030, … [Read more…]

Allurion Named to 2022 Deloitte Technology Fast 500™ List of Fastest Growing Companies

Company reports 444% revenue growth from 2018 to 2021 and has also been named as one of MedTech Outlook’s Top 10 Medtech Companies in Europe 2022 NATICK, Mass.–(BUSINESS WIRE)–Allurion, a company dedicated to ending obesity, today announced it was named to the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, … [Read more…]

Anagenex Appoints Pharmaceutical R&D Veteran Ryan Kruger as Chief Scientific Officer

BOSTON–(BUSINESS WIRE)–#CSO–Anagenex, a pioneering drug discovery company pairing large-scale data generation with machine learning to discover the next generation of small molecule medicines, today announced the appointment of Ryan Kruger, PhD, as Chief Scientific Officer. He brings 18 years of combined pharma and biotech experience, including 15 years at GSK, to his new role where … [Read more…]

Emmanuelle Toussaint, Executive Director of BIOQuébec, is Named One of Canada’s Most Inspiring Climate Leaders

BROMONT, Québec–(BUSINESS WIRE)–Emmanuelle Toussaint, Executive Director at BIOQuébec, Québec’s largest biotechnology and life sciences network, has been named one of Canada’s most inspiring climate leaders in the ‘Women in Energy Transformation Series’, an initiative by Women in Renewable Energy (WiRE), GLOBE Series and Pembina Institute. This award celebrates the most powerful women advancing Canada’s transition … [Read more…]

Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 4 on the Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies … [Read more…]

EU Addiction Policy: From Prohibition to Harm Reduction

BRUSSELS & PRAGUE–(BUSINESS WIRE)–National addiction policy makers and experts met in Brussels yesterday to discuss the Czech presidency of the Council of the EU and the best way to tackle various addictions, including alcohol, tobacco, gambling and digital technologies, at EU level. The consensus is that the priority should be a holistic, compassionate and realistic … [Read more…]

Apex Physics Partners (APP) Expands Its National Footprint with New Partnerships in Arizona and Florida

Fusion Physics, LLC and Radiation Physics & Engineering, Inc. (RPE) further Apex’s geographic reach to provide the industry’s most comprehensive medical physics service offering TOWSON, Md.–(BUSINESS WIRE)–Apex Physics Partners (APP), the largest outsourced medical physics services company in North America, today announced that two new companies, Fusion Physics, LLC in Tampa, Florida, and Radiation Physics … [Read more…]

Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month

Pushing the Future of Lung Cancer Diagnostics Forward WESTON, Mass.–(BUSINESS WIRE)–Aquyre Biosciences recognizes Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity™ microscopic system. CelTivity provides an easy-to-read image, like a PET scan for cells, making cancer cells glow. Physicians found that by using CelTivity they … [Read more…]

Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines

— Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has completed enrollment in a 678-patient Phase 2b head-to-head trial of CRV-101 against Shingrix® with data due early 2023 SEATTLE–(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective … [Read more…]